person

Wouter C.

Country
The Netherlands
Department
MDL

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Cardiovascular Medicine

The investigator concentrates on atherosclerotic cardiovascular disease, atrial fibrillation and heart failure across acute and chronic presentations.

  • Acute myocardial infarction
  • Peripheral arterial disease
  • Elevated lipoprotein(a)
  • Coronary vasospasm
  • Primary prevention of cardiovascular events

Research aims to reduce major adverse cardiovascular events and improve long‑term vascular health.

Oncology – Solid Tumors

His work spans a broad spectrum of solid malignancies, including colorectal cancer, breast cancer and lung cancer.

  • Metastatic colorectal cancer
  • Triple‑negative breast cancer
  • Advanced non‑small cell lung cancer
  • Gastric and gastro‑esophageal junction adenocarcinoma
  • Ovarian cancer with peritoneal involvement

Efforts focus on improving survival outcomes and optimizing therapeutic sequencing.

Hematologic Malignancies

The investigator is active in studies of blood cancers such as acute myeloid leukemia and chronic lymphocytic leukemia.

  • Acute myeloid leukemia (AML)
  • Chronic lymphocytic leukemia (CLL)
  • Diffuse large B‑cell lymphoma
  • Multiple myeloma
  • Myelodysplastic syndromes

Goals include enhancing remission rates and addressing treatment‑resistant disease.

Pulmonary and Respiratory Disorders

His clinical interests encompass chronic lung conditions like chronic obstructive pulmonary disease and interstitial diseases such as idiopathic pulmonary fibrosis.

  • Chronic obstructive pulmonary disease (COPD)
  • Idiopathic pulmonary fibrosis (IPF)
  • Severe eosinophilic asthma
  • Pulmonary sarcoidosis
  • Non‑cystic fibrosis bronchiectasis

Research targets disease progression control and quality‑of‑life improvement.

Metabolic and Endocrine Health

He investigates metabolic risk factors, notably obesity, type 2 diabetes and lipid abnormalities.

  • Obesity and overweight
  • Type 2 diabetes mellitus
  • Elevated lipoprotein(a) levels
  • Hypertension
  • Metabolic syndrome

Efforts aim to mitigate cardiovascular risk associated with metabolic disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.